ID: ALA2391045

Max Phase: Preclinical

Molecular Formula: C19H21N3S

Molecular Weight: 323.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2sc(CNc3ccc(N4CCCCC4)cc3)nc2c1

Standard InChI:  InChI=1S/C19H21N3S/c1-4-12-22(13-5-1)16-10-8-15(9-11-16)20-14-19-21-17-6-2-3-7-18(17)23-19/h2-3,6-11,20H,1,4-5,12-14H2

Standard InChI Key:  FKXGPAOJWLZLQD-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin reductase 269 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thioredoxin reductase 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 323.46Molecular Weight (Monoisotopic): 323.1456AlogP: 4.90#Rotatable Bonds: 4
Polar Surface Area: 28.16Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.13CX LogP: 4.34CX LogD: 4.15
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.74Np Likeness Score: -2.10

References

1. Koch O, Jäger T, Heller K, Khandavalli PC, Pretzel J, Becker K, Flohé L, Selzer PM..  (2013)  Identification of M. tuberculosis thioredoxin reductase inhibitors based on high-throughput docking using constraints.,  56  (12): [PMID:23676086] [10.1021/jm3015734]

Source